A new dermocosmetic containing retinaldehyde, delta-tocopherol glucoside and glycylglycine oleamide for managing naturally aged skin: results from in vitro to clinical studies

Study Design

Subject Type

Human

Trial Design

Open-Label

Trial Duration

56 days

Participants

36 (34 completed)

Age Range

38-56 years

Efficacy

Intervention(s)			Outcome		Method		Effect	Description
Avene A-OXitive NIGHT Peeling Cream Delta-Tocopherol Glucoside + Glycylglycine Oleamide + Retinal			Fine Lines		Profilometry		⇩	Sign in to read for free
Sign in to read for free
Avene A-OXitive NIGHT Peeling Cream Delta-Tocopherol Glucoside + Glycylglycine Oleamide + Retinal			Wrinkles		Image analysis		⇩	Sign in to read for free
Sign in to read for free

Mechanisms

Intervention(s)			Outcome		Method		Effect	Description
Delta-Tocopherol Glucoside + Glycylglycine Oleamide + Retinal			Elastic Fibres		Histology		⇧	Sign in to read for free
Sign in to read for free
Delta-Tocopherol Glucoside + Glycylglycine Oleamide + Retinal			Elastic Fibres		Assay		🠩	Sign in to read for free
Sign in to read for free
Avene A-OXitive NIGHT Peeling Cream Delta-Tocopherol Glucoside + Glycylglycine Oleamide + Retinal			Elastic Fibres		Histology		⇧	Sign in to read for free
Sign in to read for free

Side Effects

Intervention(s)			Outcome		Effect	Description
Delta-Tocopherol Glucoside + Glycylglycine Oleamide + Retinal			Skin Redness		⇧	Sign in to read for free
Sign in to read for free

Study Summary

Sign in to read for free